Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Valentino Ndaba
Be Safe on road
Be safe on the roads: Prevention is better than a hospital ward or coffin.

Safety starts with you, non-compliance ends you. A traffic spike over the Easter holidays does not justify disobeying road rules. The university is counting on all students, both drivers and pedestrians, to continue prioritising safety on the roads.

Don’t be a statistic, take responsibility
The 2018 Preliminary Easter Road Safety Report issued by the Department of Transport, indicated that most accidents were caused by irresponsibility.  “In 2018, human factor contributed 89,5% to crashes as compared to the 74,3% in 2017. The number of jay-walking pedestrians killed on our roads also increased to 38% as compared to 25,2% in 2017,” said Minister of Transport, Blade Nzimande.

The university implores you to play a role in reducing these numbers in 2019.

On driving and cellphones
According to Arrive Alive, the use of communication devices while driving is prohibited. “No person shall drive a vehicle on a public road while holding a cellular or mobile telephone or any other communication device in one or both hands or with any other part of the body, unless such a device is affixed to the vehicle or is part of the fixture in the vehicle.”

Pedestrian duties
Pedestrians are encouraged to practice caution when using sidewalks and while crossing the road. When walking, face oncoming traffic and pay attention to traffic signs so as not to constitute a source of danger to yourself or to traffic.

Safe speed saves lives
A general speed limit of 60 kilometres per hour shall apply to all public roads within urban areas, 100 kilometres per hour on public roads, and 120 kilometres per hour on freeways. Abide by these speed limits, unless stated otherwise by traffic signs.

More tips on drunken driving, wearing seat belts, and other aspects of road safety are easily available on the Arrive Alive website.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept